| Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma HEA Ali, RA Hameed, H Effat, EK Ahmed, AA Atef, SK Sharawi, M Ali, ... Clinics and research in hepatology and gastroenterology 41 (4), e51-e62, 2017 | 52 | 2017 |
| A licorice roots extract induces apoptosis and cell cycle arrest and improves metabolism via regulating MiRNAs in liver cancer cells AHA Abdel-Wahab, H Effat, EA Mahrous, MA Ali, TA Al-Shafie Nutrition and Cancer 73 (6), 1047-1058, 2021 | 24 | 2021 |
| Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype‐4) Egyptian patients M El‐Hefny, S Fouad, T Hussein, R Abdel‐Hameed, H Effat, H Mohamed, ... Journal of medical virology 91 (1), 93-101, 2019 | 22 | 2019 |
| Circulating miR-210 and miR-1246 as potential biomarkers for differentiating hepatocellular carcinoma from metastatic tumors in the liver EK Ahmed, SA Fahmy, H Effat, AHA Wahab Journal of medical biochemistry 38 (2), 109, 2019 | 20 | 2019 |
| Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients AHA E Abdelaziz, H., El-Guendy, N., Radwan, E.M., ...El-Houseini, M.E ... Asian Pacific journal of cancer prevention 23 (12), 4125–4135, 2022 | 2* | 2022 |
